Compare Indokem with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.17%
- Poor long term growth as Net Sales has grown by an annual rate of 7.63% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.38
Negative results in Mar 26
With ROCE of 2.8, it has a Very Expensive valuation with a 16.4 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.31% of the company
Stock DNA
Specialty Chemicals
INR 1,425 Cr (Micro Cap)
753.00
20
0.00%
0.35
2.90%
21.83
Total Returns (Price + Dividend) 
Indokem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Indokem Ltd is Rated Strong Sell
Indokem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Apr 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 June 2026, providing investors with the latest view of the company’s position.
Read full news article
Indokem Ltd Faces Technical Momentum Shift Amid Mixed Market Signals
Indokem Ltd, a micro-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a mildly bearish outlook. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting growing caution among traders amid recent price declines.
Read full news article
Indokem Ltd is Rated Strong Sell
Indokem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Apr 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 27 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-May-2026 | Source : BSENewspaper Publication regarding Extract of Audited Financial Results for the quarter and financial year ended 31st March 2026 as approved by the Board of Directors of the Company in its meeting held on Monday 4th May 2026 and Opening of special window for re-lodgement of transfer requests of physical shares.
Announcement under Regulation 30 (LODR)-Change in Management
04-May-2026 | Source : BSEPursuant to Regulation 30 of SEBI (LODR) Regulation 2015 we hereby inform that the Board in its meeting held today have approved the matter as mentioned in the enclosed intimation.
Results- Financial Results For 31St March 2026
04-May-2026 | Source : BSEThe Audited Standalone and Consolidated financial results for the quarter and year ended 31st March 2026 were approved by the Board of Directors at its meeting held today.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 10 Schemes (0.1%)
Held by 0 FIIs
Vindhyapriya Holdings Pvt Ltd (19.76%)
Sangeetha S (1.79%)
25.77%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is -16.41% vs 35.94% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -90.81% vs 469.90% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 1.99% vs -5.01% in Sep 2024
Growth in half year ended Sep 2025 is 180.43% vs 72.67% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.18% vs -0.87% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 337.50% vs 87.67% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -4.89% vs 8.06% in Mar 2025
YoY Growth in year ended Mar 2026 is -41.01% vs 151.21% in Mar 2025






